Porreca A, Di Nicola M, Lucarelli G, Dorin VM, et al. Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database. Urol Oncol 2024 Jan 31:S1078-1439(24)00003.
PMID: 38302296